A mixed-method study on antimicrobial resistance infection drivers in neonatal intensive care units: pathways, risks, and solutions

  23 February 2025

This study evaluates antimicrobial resistance (AMR) in neonatal intensive care units (NICUs) at Felege Hiwot Hospital. Out of 420 samples, 35% tested positive for AMR pathogens, with Coagulase-Negative Staphylococci, Klebsiella pneumoniae, and Acinetobacter spp. being the most prevalent. Resistance rates for Gentamicin, Cotrimoxazole, and Ciprofloxacin were alarmingly high, while Amikacin demonstrated low resistance. Risk factors such as improper PPE use, non-functional handwashing sinks, and inadequate disinfection practices were strongly associated with microbial contamination. Amikacin shows promise as an effective treatment for CONS.

Author(s): Almaw Genet Yeshiwas et al
Healthy Patients   Kids and Carers  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed